Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2

Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2

Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2

Bibliographic Details
Main Authors:	I. E. Chazova, M. V. Shestakova, Yu. V. Zhernakova, T. N. Markova, N. V. Mazurina, M. V. Yezhov, O. Yu. Mironova, A. Yu. Litvin, E. M. Elfimova, N. V. Blinova, O. Yu. Sukhareva, A. S. Ametov, N. M. Akhmedzhanov, O. A. Kislyak, V. V. Kukharchuk, S. V. Nedogoda, D. V. Nebieridze, I. V. Medvedev, A. M. Mkrtumyan, V. I. Podzolkov
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2020-05-01
Series:	Системные гипертензии
Subjects:	arterial hypertension diabetes mellitus type 2 metabolic disorders
Online Access:	https://syst-hypertension.ru/2075-082X/article/viewFile/34012/21720

Similar Items

Konsensus rossiyskikh ekspertovpo probleme metabolicheskogo sindromav Rossiyskoy Federatsii: opredelenie,diagnosticheskie kriterii, pervichnayaprofilaktika i lechenie
by: N M Akhmedzhanov, et al.
Published: (2010-06-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)
by: I. E. Chazova, et al.
Published: (2021-05-01)

Obesity as a predictor for cardiovascular disease development: role of localized fat depot
by: M O Azimova, et al.
Published: (2018-09-01)

Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension
by: I E Chazova, et al.
Published: (2015-09-01)

Тhе patients оf high cardiovascular risk of healthy: unrecognized metabolic syndrome
by: Blinova N.V., et al.
Published: (2016-12-01)

RUSSIAN EXPERTS’ CONSENSUS ON METABOLIC SYNDROME PROBLEM IN THE RUSSIAN FEDERATION: DEFENITION, DIAGNOSIS CRITERIA, PRIMARY PREVENTION AND TREATMENT
by: N. M. Achmegdanov, et al.
Published: (2016-01-01)

The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
by: I Ye Chazova, et al.
Published: (2017-12-01)

The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
by: Chazova I.Ye., et al.
Published: (2017-09-01)

Epicardial fat: a new cardiometabolic risk marker, a new therapeutic goal in obese patients
by: N V Blinova, et al.
Published: (2018-12-01)

The patients of high cardiovascular risk of healthy: unrecognized metabolic syndrome
by: N V Blinova, et al.
Published: (2016-12-01)

Consensus on patients with hyperuricemia and high cardiovascular risk treatment
by: Irina E Chazova, et al.
Published: (2019-12-01)

Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)
by: I. E. Chazova, et al.
Published: (2022-10-01)

OPPORTUNITIES FOR EARLY OUTPATIENT DIAGNOSTICS OF OBSTRUCTIVE SLEEP DISORDERED BREATHING
by: V. N. Larina, et al.
Published: (2018-06-01)

Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension
by: E M Elfimova, et al.
Published: (2015-06-01)

Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure
by: A V Aksenova, et al.
Published: (2016-06-01)

Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure
by: Aksenova A.V., et al.
Published: (2016-06-01)

NON-ADHERENT BEHAVIOR IN PATIENTS WITH ANXIETY AND HYPERTENSION: FOCUS ON NON-PHARMACOLOGICAL TREATMENT AS A METHOD TO INCREASE COMPLIANCE
by: I. A. Viktorova, et al.
Published: (2017-01-01)

Dostizhenie tselevykh urovney arterial'nogo davleniya na fone priema fiksirovannoy kombinatsii perindoprila 10 mg i indapamida 2,5 mg u patsientov s nekontroliruemoy arterial'noy gipertenziey 2-3-y stepeni
by: I E Chazova, et al.
Published: (2012-03-01)

EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE
by: V. P. Mikhin, et al.
Published: (2015-12-01)

Correction of hypertriglyceridemia in order to reduce the residual risk in atherosclerosis-related diseases. Expert Council Opinion
by: G. P. Arutyunov, et al.
Published: (2019-09-01)

Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board
by: M. V. Shestakova, et al.
Published: (2022-01-01)

Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients
by: Yu V Zhernakova, et al.
Published: (2017-03-01)

Consensus of experts from the Russian Medical Society of Arterial Hypertension. Arterial hypertension and erectile dysfunction
by: Tatiana A. Alekseeva, et al.
Published: (2021-07-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

Strategiya antigipertenzivnoy terapii u pozhilykh bol'nykh arterial'noy gipertenziey s vysokim riskom serdechno-sosudistykh oslozhneniy: rezul'taty Rossiyskogo issledovaniya KhARIZMA-3
by: I E Chazova, et al.
Published: (2012-09-01)

Polypill" conception in modern cardiology
by: I E Chazova, et al.
Published: (2018-12-01)

Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council
by: M. V. Ezhov, et al.
Published: (2021-03-01)

A clinical case of hemangioma of the face and tongue concurrent with severe obstructive sleep apnea syndrome complicated by cardiac arrhythmias and conduction disturbances
by: K I Konovalova, et al.
Published: (2016-08-01)

Hypertension treatment features in perimenopausal women
by: Yu V Zhernakova, et al.
Published: (2014-03-01)

Control of cardiovascular risk in patients with diabetes
by: Yu V Zhernakova, et al.
Published: (2016-09-01)

Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders
by: Yu V Zhernakova, et al.
Published: (2014-06-01)

Vliyanie chisla odnovremennovstrechayushchikhsya komponentovmetabolicheskogo sindroma na tyazhest'arterial'noy gipertonii,rasprostranennost' i vyrazhennost'porazheniya organov-misheneyu dannykh bol'nykh
by: Yu V Zhernakova, et al.
Published: (2011-09-01)

Guidelines for diagnostics and treatment of hypertension 2018 – European experts’opinion
by: I.E.Chazova, et al.
Published: (2018-08-01)

Calcium channel blockers: more than 50 years on guard of health
by: I E Chazova, et al.
Published: (2015-06-01)

Control of cardiovascular risk in patients with diabetes
by: Zhernakova Yu.V., et al.
Published: (2016-08-01)

Diagnosis and treatment of arterial hypertension [Guidelines]
by: I E Chazova, et al.
Published: (2019-03-01)

Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]
by: I E Chazova, et al.
Published: (2018-09-01)

The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan
by: Yu V Zhernakova, et al.
Published: (2016-09-01)